News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pulmonx, Inc. Study Confirms Minimally-Invasive Pulmonx Therapy Effectively Treats Emphysema


9/26/2011 9:33:16 AM

AMSTERDAM--(BUSINESS WIRE)--Pulmonx has just announced final results of its Chartis multi-centre study 1, presented today at the European Respiratory Society’s 2011 Congress. This definitive data confirms that use of the Chartis® Pulmonary Assessment System to plan Zephyr® valve treatments is the key to successful EBV treatment of emphysema.

Read at BioSpace.com


comments powered by Disqus
   
Emphysema

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES